Clinical Trial Update: A Safety and Tolerability Study of ABT-126 in Elderly [Phase 1]

View source ↗

Summary

A Phase 1 safety and tolerability trial of ABT-126 in elderly individuals with Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ABT-126

Snippet

Sponsor: Abbott | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED